TR200003858T2 - 4,5,6 ve D-indol ve indolin türevlerinin kullanımı. - Google Patents

4,5,6 ve D-indol ve indolin türevlerinin kullanımı.

Info

Publication number
TR200003858T2
TR200003858T2 TR2000/03858T TR200003858T TR200003858T2 TR 200003858 T2 TR200003858 T2 TR 200003858T2 TR 2000/03858 T TR2000/03858 T TR 2000/03858T TR 200003858 T TR200003858 T TR 200003858T TR 200003858 T2 TR200003858 T2 TR 200003858T2
Authority
TR
Turkey
Prior art keywords
indole
indoline derivatives
formula
iic
iib
Prior art date
Application number
TR2000/03858T
Other languages
English (en)
Inventor
Knud Moltzen Ejner
Mikkelsen Ivan
Krog-Jensen Christian
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of TR200003858T2 publication Critical patent/TR200003858T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Formül (I) olan, A'nin formülü (IIA), (IIB), (IIC) olan ve X, U, Y, R3 ila R12, Z, W, n ve m'nin yukarida tarif edildigi gibi oldugu ikame edilmis 4-, 5-, 6-, ve 7-indol veya indolin türevleri. Bu bilesikler serotonin geri alimini inhibe eden güçlü maddelerdir ve 5-HT1A reseptörü antagonisti aktivitesine sahiptirler.
TR2000/03858T 1998-06-19 1999-06-14 4,5,6 ve D-indol ve indolin türevlerinin kullanımı. TR200003858T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK82098 1998-06-19

Publications (1)

Publication Number Publication Date
TR200003858T2 true TR200003858T2 (tr) 2001-06-21

Family

ID=8097932

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03858T TR200003858T2 (tr) 1998-06-19 1999-06-14 4,5,6 ve D-indol ve indolin türevlerinin kullanımı.

Country Status (16)

Country Link
US (2) US6391882B1 (tr)
KR (1) KR20010071513A (tr)
CN (1) CN1336925A (tr)
AR (1) AR018899A1 (tr)
BR (1) BR9911843A (tr)
CZ (1) CZ20004780A3 (tr)
EA (1) EA004248B1 (tr)
HK (1) HK1044339A1 (tr)
ID (1) ID27976A (tr)
IL (1) IL139962A0 (tr)
IS (1) IS5731A (tr)
PL (1) PL344978A1 (tr)
SK (1) SK19412000A3 (tr)
TR (1) TR200003858T2 (tr)
YU (1) YU78100A (tr)
ZA (1) ZA200007157B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4919565B2 (ja) * 1999-08-23 2012-04-18 アボツト・ヘルスケア・プロダクツ・ベー・ブイ 新規なフェニルピペラジン
DE10219035A1 (de) * 2002-04-29 2003-11-13 Bayer Cropscience Ag Biphenylcarboxamide
US7153858B2 (en) * 2003-01-31 2006-12-26 Epix Delaware, Inc. Arylpiperazinyl compounds
MX2009004898A (es) 2006-11-09 2009-05-19 Hoffmann La Roche Derivados de indol y de benzofurano-2-carboxamida.
WO2010051561A1 (en) * 2008-11-03 2010-05-06 Chemocentryx, Inc. Compounds for the treatment of osteoporosis and cancers
CA2794153C (en) 2010-03-25 2018-01-02 Glaxosmithkline Llc Substituted indoline derivatives as perk inhibitors
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305641D0 (en) 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
DE4414113A1 (de) 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
IL114026A (en) * 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them
ZA9711376B (en) 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives

Also Published As

Publication number Publication date
AR018899A1 (es) 2001-12-12
IL139962A0 (en) 2002-02-10
ZA200007157B (en) 2001-11-22
EA200100056A1 (ru) 2001-06-25
EA004248B1 (ru) 2004-02-26
HK1044339A1 (zh) 2002-10-18
YU78100A (sh) 2003-04-30
SK19412000A3 (sk) 2001-07-10
ID27976A (id) 2001-05-03
US6391882B1 (en) 2002-05-21
CZ20004780A3 (cs) 2001-08-15
BR9911843A (pt) 2001-03-20
US20020128272A1 (en) 2002-09-12
KR20010071513A (ko) 2001-07-28
PL344978A1 (en) 2001-11-19
CN1336925A (zh) 2002-02-20
IS5731A (is) 2000-11-24

Similar Documents

Publication Publication Date Title
ATE252575T1 (de) Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
TR199901407T2 (tr) Indan veya dihidroindol türevleri.
NO20032253L (no) Piperazinylpyrazinforbindelser som antagonister av serotonin 5-HT2-reseptorer
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
BR0306150A (pt) Composto, uso de um composto, e, composição farmacêutica
NO20060154L (no) Imidazolyl-derivater
TR200101398T2 (tr) Pirolidin türevleri-CCR-3 reseptörü antagonistleri.
ATE297910T1 (de) Retinoid x rezeptormodulatoren
ATE245644T1 (de) 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin rezeptoren v1b oder v1b und v1a
ATE416767T1 (de) 5-halo-tryptaminderivate als 5-ht6 und/oder 5-ht7 rezeptorliganden
BR0206595A (pt) Composto, composição farmacêutica, e uso de um composto
TR199902590T2 (tr) Birlesik 5HT1A 5HT1B ve 5HT1D reseptör antagonist aktivitesi olan indol türevleri.
EA200300619A1 (ru) Серотонинергические средства
EA200200732A1 (ru) Замещенные производные фенилпиперазина, их получение и применение
TR200003858T2 (tr) 4,5,6 ve D-indol ve indolin türevlerinin kullanımı.
HUP9801386A2 (hu) Szerotonin 5-HT4 receptor parciális agonistáiként és antagonistáiként alkalmazható indazol-karboxamid-származékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
DE60131001D1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
MXPA04006113A (es) Derivados de triazoloquinolina utiles como ligandos receptores de adenosina.
EA200200727A1 (ru) Новые производные индола
TR199802552T2 (tr) 5-HT-2C Reseptör karsitlari olarak faydali indolin türevleri.
ATE253058T1 (de) Piperidin- und piperazin derivate als 5-ht1- rezeptor-agonisten